United States

People: Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

22 Feb 2019
Change (% chg)

$0.05 (+0.43%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Forman, Alan 

Mr. Alan S. Forman serves as an Independent Director of the Company. Mr. Forman is a Director of Investments at the Yale University Investments Office, the team charged with managing the University’s $25 billion dollar endowment fund. Mr. Forman has been a leader at the Investment Office for more than two decades during which time the office has become one of the top performing institutions in the world. While at the institution, he has executed billions of dollars of transactions across numerous investment cycles and industries. Mr. Forman served on the board of directors of Acadia Realty Trust, a public company, where he served as Chairman of Acadia’s Compensation Committee and was a member of the Nominating and Corporate Governance Committees. He worked closely with the CEO and other board members on a wide range of strategic issues with particular emphasis on corporate strategy, company structure, M&A and fund raising, and was instrumental in the company’s success. Mr. Forman was also on the board of directors of Kimpton Group Holdings, which was ultimately sold to Intercontinental Hotels Group. He served on the Compensation and Nominating and Governance Committees. After having sourced and structured the original investment, he then joined the board, served as a close advisor to the CEO and CFO, and was a key member of the team that orchestrated the company’s successful acquisition. Mr. Forman received his B.A. degree from Dartmouth College and an M.B.A. degree from NYU’s Stern Graduate School of Business. We believe Mr. Forman is qualified to serve on our Board of Directors due to his extensive financial and management experience for both public and private entities and his experience serving as member of the board of directors of other companies.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 82,000
Long-Term Incentive Plans, USD --
All Other, USD 187,631
Fiscal Year Total, USD 269,631

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ivan Bergstein


Kenneth Hoberman


David Gionco


Ron Bentsur


Eric Dobmeier


Alan Forman

As Of  30 Dec 2017